CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer. - Lopez CD; Kardosh A; Chen EY; Pegna G; Guimaraes A; Foster B; Brinkerhoff B; Goodyear SM; Lim JY; Taber E; Rajagopalan B; Edmerson E; et al. (Future oncology (London, England), 2024)